tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP

Neuphoria Therapeutics (NEUP) Similar Stocks

Compare
234 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Neuphoria Therapeutics
$5.04
$7.15M
-54.26%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biogen
$142.37
$21.30B
13.21
-40.75%
8 Buy
13 Hold
0 Sell
Moderate Buy
Incyte
$74.95
$13.98B
514.09
30.67%
5 Buy
8 Hold
1 Sell
Moderate Buy
Neurocrine
$150.51
$15.06B
39.84
11.97%
17 Buy
4 Hold
0 Sell
Strong Buy
Regeneron
$722.07
$76.33B
16.72
-23.71%
15 Buy
3 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$481.16
$113.24B
13.73%
14 Buy
10 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
NEUP
Neuphoria Therapeutics
5.04
-5.68
-52.99%
BIIB
Biogen
142.37
-98.17
-40.81%
INCY
Incyte
74.95
17.61
30.71%
NBIX
Neurocrine
150.51
14.22
10.43%
REGN
Regeneron
722.07
-216.42
-23.06%
VRTX
Vertex Pharmaceuticals
481.16
62.08
14.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis